T-cell response in human leishmaniasis

Immunology Letters

Volumn 65, Issue 1-2, 1999, Pages 105-108

  Kharazmi, A ^a,b   Kemp, K ^a   Ismail, A ^b   Gasim, S ^b   Gaafar, A ^b   Kurtzhals, J A L ^a   El Hassan, A M ^c   Theander, T G ^b   Kemp, M ^a  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

CONFERENCE PAPER; HOST RESISTANCE; HUMAN; IMMUNOREACTIVITY; IMMUNOREGULATION; INTERFERON PRODUCTION; LEISHMANIA DONOVANI; LEISHMANIASIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, PROTOZOAN; CYTOKINES; HUMANS; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; T-LYMPHOCYTES;

EID: 0032972363     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(98)00132-1     Document Type: Conference Paper

References (19)

1. Badaro R., Carvalho J.S., Badaro F. et al. vanFurth R. Hemopoietic Growth Factors and Mononuclear Phagocytes. 1993;111-122 Karger.
2. Pirmez C., Yamamura M., Uemura K., Paes-Oliverira M., Conseicao-Silva F., Modlin R. L. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest. 91:1993;1390-1395.
3. Carvalho E.M., Barral A., Pedral-Sampario D. et al. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. J. Infect. Dis. 165:1992;535-540.
4. Karp C.L., El Safi S.H., Wynn T.A. et al. In vivo cytokine profiles in patients with kala-azar. J. Clin. Invest. 91:1993;1644-1648.
5. Kemp M., Hey A.S., Kurtzhals J.A.L., Christensen C.B.V., Gaafar A., Mustafa D.M., Kordofani A., Ismail A., Kharazmi A., Theander T.G. Dichotomy of the human T-cell response to Leishmania antigens. I. Th1 like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Clin. Exp. Immunol. 96:1994;410-415.
6. Kemp M., Hey A., Brendtzen K., Kharazmi A., Theander T.G. Th1-like human T-cell clones recognizing Leishmania gp63 inhibit Leishmania major in human macrophages. Scand. J. Immunol. 40:1994;629-635.
7. Gaafar A., Kharazmi A., Ismail A., Kemp M., Hey A.S., Christensen C.B.V., Mustafa M.D., Kadaro A., Elhassan A., Theander T.G. Dichotomy of the T-cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis. Absence or scarcity of Th1 activity is associated with severe infections. Clin. Exp. Immunol. 100:1995;239-245.
8. Carvalho E.M., Badaro R., Reed S.G., Jones T.C., Johnson W.D. Jr Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J. Clin. Invest. 76:1985;2066-2069.
9. Ho M., Koech D.K., Iha D.W., Brycesson A.D.M. Immunosuppression in Kenyan visceral leishmanisis. Clin. Exp. Immunol. 51:1983;207-214.
10. Zwingenberger K., Harms G., Pedrosa C., Omena S., Sandkamp B., Neifer S. Determinants of the immune response in visceral leishmaniasis: evidence for predominanace of endogenous interleukin 4 over interferon-gamma production. Clin. Immunol. Immunopathol. 57:1990;242-249.
11. Galvao-Castro B., Ferreira J.A.S.A., Marzochi K.F., Marzochi M.C., Countinho S.G., Lambert P.H. Polyclonal B-cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis. Clin. Exp. Immunol. 56:1984;58-66.
12. Cillari E., Vitale G., Arcoleo F. et al. In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmanisis. Cytokine. 7:1995;740-745.
13. Ghalib H.W., Piuvezam M.R., Sheiky Y. et al. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92:1993;324-329.
14. Holaday B.J., Pompeu M.M., Jeronimo S., Texeira M.J., de Sousa A. Potential role for interleukin 10 in the immune suppression associated with kala-azar. J. Clin. Invest. 92:1993;2626-2632.
15. Kurtzhals J.A.L., Hey A.S., Jardim A., Kemp M., Schaefer K.U., Odera E.O., Christensen C.B.V., Githure J.I., Olafson R.W., Theander T.G., Kharazmi A. Dichotomy of the human T-cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients. Clin. Exp. Immunol. 96:1994;416-421.
16. Ismail A., Kharazmi A., Permin H., ElHassan A.M. Detection and characterization of Leishmania parasites in tissues of post kala-azar dermal leishmaniasis using a specific monoclonal antibody. Trans. Roy. Soc. Trop. Med. Hyg. 91:1997;283-285.
17. Gasim S., ElHassan A.M., Khalil E.A.G., Ismail A., Kadaro A.A., Kharazmi A., Theander T.G. High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis. Clin. Exp. Immunol. 111:1998;64-69.
18. ElHassan A.M., Ghalib H.W., Zilstra E.E., ElToum I.A., Satti M., Ali M.S., Ali H.M.A. Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment. Trans. Roy. Soc. Trop. Med. Hyg. 86:1992;245-248.
19. Kemp M., Theander T.G., Kharazmi A. The contrasting roles of CD4+T-cells in intracellular infections in human: Leishmania as an example. Immunol. Today. 17:1996;13-16.